Emily L Ashkin

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes

S. Hanash, R. Amaria, P. Hwu, 2017, Nature Communications.

A functional taxonomy of tumor suppression in oncogenic KRAS-driven lung cancer.

Christopher D. McFarland, Min K. Tsai, D. Petrov, 2021, Cancer discovery.

Combinatorial Inactivation of Tumor Suppressors Efficiently Initiates Lung Adenocarcinoma with Therapeutic Vulnerabilities.

Min K. Tsai, D. Petrov, C. Swanton, 2022, Cancer research.

Combinatorial tumor suppressor inactivation efficiently initiates lung adenocarcinoma with therapeutic vulnerabilities

Min K. Tsai, D. Petrov, C. Swanton, 2021, bioRxiv.

Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity

R. Amaria, P. Hwu, F. Muller, 2020, Cancer Immunology, Immunotherapy.

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes

R. Davis, S. Hanash, Min Zhang, 2017, Nature Communications.

The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy

R. Davis, C. Liu, A. Sood, 2017, Journal of the National Cancer Institute.

Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages

Min K. Tsai, Maryam Yousefi, Christopher W Murray, 2023, The Journal of experimental medicine.